No Data
No Data
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 X CD3 T-Cell Engager
CEO's Bold Move: Massive Stock Purchase Signals Confidence in Abpro Holdings!
10-K: FY2024 Annual Report
Express News | Abpro Holdings Inc - to Restate Some Prior Period Financial Statements - SEC Filing
Abpro Holdings to Present Preclinical Data at AACR 2025
Express News | Abpro Announces Oral Presentation of First Preclinical Data for Abp-102/Ct-P72, a Tetravalent Bispecific Her2 X Cd3 T-Cell Engager, at AACR Annual Meeting 2025